Rockgod, you said that you have performed a thorough analysis of the company for more than one month. Yet the results of that in-depth analysis appears to consists of a series of sweeping generalizations, followed by the statement "I can not find any redeeming qualities about this company." You also rule shorting the stock, stating "I don't short on the stock market." Seems to be little reason to remain interested in Unilife.
As for me, the +100% increase in share price over the past year, coupled with five consecutive contracts with leading pharmaceutical companies and the assurance of more to follow is more than enough to maintain my interest. Seems like a pretty hard sell to convince those who have, and continue, to make excellent returns on their UNS/UNIS investments that there are no "redeeming qualities" to the company.
Good luck to you on your other investments.
investor briefings, page-48
-
- There are more pages in this discussion • 92 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)